3 papers in the library · 97 citations · publishing 2021-2024
JAMA August 1, 2021 William R. Smith, Paul S. Appelbaum 60 citations
Psychedelic substance legalization initiatives raise concerns that can be informed by cautionary precedents from the legalization and commercialization of other controlled substances.
American Journal of Bioethics May 2, 2024 Edward Jacobs, B. Earp, Paul S. Appelbaum et al. 29 citations
A workshop on psychedelic ethics, the first Hopkins-Oxford Psychedelic Ethics (HOPE) meeting, was held in August 2023 at the University of Oxford to address ethical issues surrounding psychedelics. The organizers (BDE, DBY, EJ) aimed to foster interdisciplinary discussion on topics such as informed consent, therapeutic use, and societal implications. The report outlines the workshop's structure, key themes, and proposed guidelines for ethical research and practice in the field.
Nature Medicine January 1, 2024 William Smith, Dominic Sisti, Paul S. Appelbaum 8 citations
No Summary